Antioxidants (Jan 2023)

Ether Lipid-Mediated Antioxidant Defense in Alzheimer’s Disease

  • Mariona Jové,
  • Natàlia Mota-Martorell,
  • Èlia Obis,
  • Joaquim Sol,
  • Meritxell Martín-Garí,
  • Isidre Ferrer,
  • Manuel Portero-Otin,
  • Reinald Pamplona

DOI
https://doi.org/10.3390/antiox12020293
Journal volume & issue
Vol. 12, no. 2
p. 293

Abstract

Read online

One of the richest tissues in lipid content and diversity of the human body is the brain. The human brain is constitutively highly vulnerable to oxidative stress. This oxidative stress is a determinant in brain aging, as well as in the onset and progression of sporadic (late-onset) Alzheimer’s disease (sAD). Glycerophospholipids are the main lipid category widely distributed in neural cell membranes, with a very significant presence for the ether lipid subclass. Ether lipids have played a key role in the evolution of the human brain compositional specificity and functionality. Ether lipids determine the neural membrane structural and functional properties, membrane trafficking, cell signaling and antioxidant defense mechanisms. Here, we explore the idea that ether lipids actively participate in the pathogenesis of sAD. Firstly, we evaluate the quantitative relevance of ether lipids in the human brain composition, as well as their role in the human brain evolution. Then, we analyze the implications of ether lipids in neural cell physiology, highlighting their inherent antioxidant properties. Finally, we discuss changes in ether lipid content associated with sAD and their physiopathological implications, and propose a mechanism that, as a vicious cycle, explains the potential significance of ether lipids in sAD.

Keywords